A 5-year Longitudinal Observational Study of Patients with Nonalcoholic Fatty Liver or Nonalcoholic Steatohepatitis Save

Date Added
February 28th, 2017
PRO Number
Pro00062843
Researcher
David Koch
Keywords
Disease Prevention, Genetics, Liver, Obesity, Weight Control
Summary

This is a 5-year, longitudinal, observational study of patients with NAFL or NASH designed to specifically address important clinical questions that remain incompletely answered from registration trials. In addition to the study database, a bio specimen repository will also be included so that translational studies of genomics and biomarkers of response may be performed.

Institution
MUSC
Recruitment Contact
Francis Beylotte
843-876-4273
beylott@musc.edu

A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma Save

Date Added
February 28th, 2017
PRO Number
Pro00062918
Researcher
David Koch
Keywords
Cancer, Cancer/Gastrointestinal, Cancer/Other, Digestive System, Genetics, Liver, Obesity, Weight Control
Summary

TARGET-HCC is a 5-year, longitudinal, observational study of the natural history and management of patients with HCC. The study will address important clinical questions that remain unanswered in the management of HCC with a unique research registry of participants with HCC from academic and community real-world practices. TARGET-HCC is disease focused, not drug specific, which allows for continuous acquisition of real-world evidence regarding the natural history, management, and outcomes of treatment with current therapies and new treatments that may be utilized in usual clinical practice.

Institution
MUSC
Recruitment Contact
Francis Beylotte
843-876-4273
beylott@musc.edu

ALFSG-MBT-003: 13C-Methacetin Breath Test for the Prediction of Outcome in Acute Liver Failure (ALF-MBT) Save

Date Added
May 17th, 2016
PRO Number
Pro00053899
Researcher
David Koch
Keywords
Liver, Transplant
Summary

This is an inpatient study to prove that the Methacetin Breath Test is a reliable tool to help doctors identify patients with acute liver failure who will or will not need a liver transplant.

Institution
MUSC
Recruitment Contact
Melanie Crolley
843-876-4273
crolley@musc.edu

Sorafenib in Patients with Hepatopulmonary Syndrome: A Double-Blind Randomized Clinical Trial Save

Date Added
March 15th, 2016
PRO Number
Pro00051418
Researcher
David Koch
Keywords
Liver, Transplant
Summary

This is a research study to test the safety and effectiveness of the study drug sorafenib, in adults diagnosed with hepatopulmonary syndrome.

Institution
MUSC
Recruitment Contact
Melanie Crolley
843-876-4273
crolley@musc.edu

Change_preferences

-- OR --

Create_login